论文部分内容阅读
1商品名Elaprase 2开发与上市厂商美国Shire公司研制开发,2006年9月首次在美国上市,本品在欧盟和美国获得罕用药身份。本品适用于Ⅱ型黏多糖增多症(Hunter综合征,MPSll)患者的长期治疗。
1 Trade Name Elaprase 2 Developed and Listed Manufacturer Shire Corporation, USA Developed and developed in September 2006 for the first time in the United States. This product is rarely used in the EU and the United States. This product is suitable for long-term treatment of patients with type 2 mucopolysaccharidosis (Hunter syndrome, MPSll).